Support a healthier future

SVI is home to Australia’s largest group of type 1 diabetes researchers, who are working passionately to better understand this debilitating condition and develop better treatments and a cure.  

Last December, we proudly published the results of a world-first type 1 diabetes clinical trial, that offers new hope for improved treatment options.  

At SVI, we remain dedicated to improving the lives of those affected by type 1 diabetes.  

Meet Anna Johnston 

Anna was diagnosed with type 1 diabetes 3 years ago, at the age of 11, following in the tracks of her brother’s diagnosis 9 years earlier.

Anna and her mother Sarah-Jane spoke about how type 1 diabetes impacts their daily lives and why they chose to participate in our clinical trial.  

“Every decision we make as a family revolves around managing Anna’s diabetes, and my son Max’s as well,” said Sarah-Jane, Anna’s mother.  

“Finding a cure for type 1 diabetes would mean everything to us, and I truly believe that research is the only path forward.” 

For Anna’s family, type 1 diabetes has become a part of daily life. 

Anna shared, “When I joined the clinical trial, I wasn’t just thinking about my own future, but also how it could improve the lives of future generations—potentially my own children, who may inherit type 1 diabetes. These trials are the only way to give them a life free from injections, medical appointments, infusion pumps, and constant trips to the hospital.” 

Anna and Max’s story is not unique. It reflects the urgent need for continued research and funding. Our recent trial exemplifies the groundbreaking work being done at SVI.  

This research has the potential to revolutionise the treatment landscape for type 1 diabetes, providing hope for people like Anna and Max, who face the daily challenges of managing this relentless condition. 

By supporting SVI, you are directly contributing to the ongoing research that can lead to improved treatments and, ultimately, a cure for type 1 diabetes.  

Discover how you can make a real difference in advancing diabetes research at SVI